Effects of Sildenafil on Cyclic Nucleotide Production in Adrenergic Receptor Signaling of Type 2 Diabetic-Related Heart Failure

Text Registration

Effects of Sildenafil on Cyclic Nucleotide Production in Adrenergic Receptor Signaling of Type 2 Diabetic-Related Heart Failure

Status

Published

on 18 Mar 2019

Year of Creation

2018

Toni Mcclish West

Registration Number

TX0008691644

on 18 Mar 2019

The U.S. Copyright record (Registration Number: TX0008691644) dated 18 Mar 2019, pertains to an electronic file (eService) titled "Effects of Sildenafil on Cyclic Nucleotide Production in Adrenergic Receptor Signaling of Type 2 Diabetic-Related Heart Failure" created in 2018. The copyright holder is Toni Mcclish West, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Toni Mcclish West.

Toni Mcclish West

Application Details

Registration Number

TX0008691644

Registration Date

3/18/2019

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Toni McClish West

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Effects of Sildenafil on Cyclic Nucleotide Production in Adrenergic Receptor Signaling of Type 2 Diabetic-Related Heart Failure

Author Statement: Toni McClish West Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Effects of Sildenafil on Cyclic Nucleotide Production in Adrenergic Receptor Signaling of Type 2 Diabetic-Related Heart Failure

Author Statement: Toni McClish West Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.